Adenosine deaminase 2 (ADA2) has been identified as a regulator of toll-like receptor 9 (TLR9) activation in response to nucleic acids, according to a recent study.

Researchers at the University of Chicago have successfully captured detailed images of adhesion G protein-coupled receptors, ...

The US subsidiary of Japan’s Sumitomo Pharma announced that the US Food and Drug Administration (FDA) has approved Gemtesa ...

A drug recently approved to prevent migraine may start working right away, according to a study published in the December 23, ...